FrancophonIA/ELRC3.0 huggingface dataset:
English: The main measure of effectiveness was the number of patients who had no nausea and vomiting in the five days after receiving chemotherapy.
Croatian: Glavna je mjera učinkovitosti bio broj bolesnika koji nisu osjećali mučninu ili nisu povraćali pet dana nakon primanja kemoterapije.
English: The CHMP decided that Emend's benefits are greater than its risks and recommended that it be given marketing authorisation.
Croatian: CHMP je odlučio da koristi od lijeka Emend nadmašuju s njim povezane rizike te je preporučio izdavanje odobrenja za stavljanje u promet.
English: It is only given on the first day of the chemotherapy and is followed by treatment involving a corticosteroid and a 5HT3 antagonist.
Croatian: Daje se samo prvoga dana kemoterapije, a nakon njega slijedi liječenje koje uključuje kortikosteroid i antagonist 5HT3.
English: Emend is an antiemetic, a medicine that prevents nausea (feeling sick) and vomiting.
Croatian: Emend je antiemetik, lijek koji sprečava mučninu (osjećaj slabosti) i povraćanje.
English: It must be given with other medicines that also prevent nausea and vomiting, including a corticosteroid (such as dexamethasone) and a ‘5-HT3 antagonist' (such as ondansetron).
Croatian: Mora se davati s drugim lijekovima koji također sprečavaju mučninu i povraćanje, uključujući kortikosteroid (kao što je deksametazon) i „antagonist 5HT3” (kao što je ondansetron).
English: Emend 165 mg is given to adults only once, one hour before the start of chemotherapy.
Croatian: Emend 165 mg daje se odraslima samo jedanput, jedan sat prije početka kemoterapije.
English: Emend is used with other medicines to prevent nausea and vomiting caused by chemotherapy (medicines used to treat cancer).
Croatian: Emend se upotrebljava s drugim lijekovima za sprečavanje mučnine i povraćanja uzrokovanih kemoterapijom (lijekovi koji se upotrebljavaju za liječenje raka).
English: What is the risk associated with Emend?
Croatian: Koji su rizici povezani s lijekom Emend?
English: By blocking the receptors, Emend can prevent nausea and vomiting, which often happens after chemotherapy or as a complication of surgery.
Croatian: Blokirajući receptore, Emend može spriječiti mučninu i povraćanje, koji se često javljaju nakon kemoterapije ili kao postoperativna komplikacija.
English: In chemotherapy, three main studies have been carried out for Emend 80 and 125 mg capsules.
Croatian: U pogledu kemoterapije provedena su tri glavna ispitivanja kapsula Emenda od 80 i 125 mg.
English: It is used with chemotherapy that is a moderate or high trigger of nausea and vomiting such as cisplatin, cyclophosphamide, doxorubicin or epirubicin.
Croatian: Upotrebljava se uz kemoterapiju koja uzrokuje umjerenu do snažnu mučninu i povraćanje, kao što su cisplatin, ciklofosfamid, doksorubicin ili epirubicin.
English: In PONV, the usual dose is one 40 mg capsule given to adults within the three hours before the patient is anaesthetised (‘put to sleep').
Croatian: Kod PONV-a uobičajena je doza jedna kapsula od 40 mg koja se odraslima daje tri sata prije anesteziranja („uspavljivanja”) bolesnika.
English: It is available as capsules (40, 80, 125 and 165 mg) and as a powder to be made up into an oral (by mouth) suspension (125 mg).
Croatian: Dostupan je u kapsulama (40, 80, 125 i 165 mg) i u prahu za pripravljanje oralne (na usta) suspenzije (125 mg).
English: The effectiveness of Emend was also seen during a further five cycles of chemotherapy.
Croatian: Učinkovitost lijeka Emend zabilježena je i tijekom sljedećih pet ciklusa kemoterapije.
English: Emend oral suspension is given one hour before the start of chemotherapy, and for the next 2 days.
Croatian: Oralna suspenzija Emend daje se jedan sat prije početka kemoterapije te sljedeća dva dana.
English: The studies measured how many patients had a complete response, which was defined as no vomiting and no need for any other medication to control nausea and vomiting in the 24 hours after the operation.
Croatian: U ispitivanjima se mjerilo koliko je bolesnika imalo potpunu reakciju, koja se definirala kao izostanak povraćanja te potrebe za drugim lijekovima za kontrolu mučnine i povraćanja tijekom 24 sata nakon operacije.
English: What is Emend?
Croatian: Što je Emend?
English: Tests were performed to determine that Emend 165 mg produces the same amount of aprepitant in the body as a single dose of 150 mg Ivemend.
Croatian: Obavljeno je testiranje kako bi se utvrdilo proizvodi li Emend 165 mg jednaku količinu aprepitanta u tijelu kao jedna doza lijeka Ivemend od 150 mg.
English: A fourth study has been carried out with Emend (125 mg capsules or 125 mg oral solution) in 307 children from 6 months to 17 years of age, where Emend, taken with ondansetron (with or without dexamethasone), was compared with ondansetron alone (with or without dexamethasone).
Croatian: Četvrto ispitivanje lijeka Emend (kapsule od 125 mg ili otopina za oralnu primjenu od 125 mg) provedeno je na uzorku od 307 djece u dobi od 6 mjeseci do 17 godina, gdje se Emend, primijenjen uz ondansetron (s deksametazonom ili bez njega), uspoređivao s primjenom samoga ondansetrona (s deksametazonom ili bez njega).
English: Emend 80, 125 and 165 mg capsules are used in adults; children from 12 years of age may be given the 80- or 125-mg capsules and children between 6 months and 12 years of age are given the oral suspension.
Croatian: Kapsule lijeka Emend od 80, 125 i 165 mg upotrebljavaju se u odraslih; djeci starijoj od 12 godina mogu se dati kapsule od 80 ili 125 mg, a djeci od 6 mjeseci do 12 godina starosti daje se oralna suspenzija.
English: Two doses of Emend (40 and 125 mg as capsules) were compared with ondansetron given as an injection.
Croatian: Dvije doze lijeka Emend (kapsule od 40 i 125 mg) uspoređene su s ondansetronom koji se daje kao injekcija.
English: At a dose of 80, 125 and 165 mg, the other side effects seen in between 1 and 10 patients in 100 are headache, hiccups, constipation, dyspepsia (indigestion), loss of appetite, and fatigue (tiredness).
Croatian: Pri dozi od 80, 125 i 165 mg ostale nuspojave koje se mogu javiti u 1 do 10 bolesnika na 100 jesu sljedeće: glavobolja, štucanje, zatvor, dispepsija (žgaravica), gubitak apetita te iscrpljenost (umor).
English: In chemotherapy, the usual dose of Emend in adults and children from 12 years of age is one 125 mg capsule by mouth one hour before the start of chemotherapy.
Croatian: Tijekom kemoterapije uobičajena je doza lijeka Emend u odraslih i djece starije od 12 godina jedna kapsula od 125 mg oralno jedan sat prije početka kemoterapije.
English: In the study in children, around 51% (77 out of 152) of children given Emend with ondansetron had a complete response 25 to 120 hours after beginning chemotherapy, compared with 26% (39 out of 150) of children given ondansetron alone.
Croatian: U ispitivanju provedenome među djecom, u otprilike 51% (77 od 152) djece koja su primala Emend s ondansetronom zabilježena je potpuna reakcija 25 do 120 sati nakon početka kemoterapije, u usporedbi s 26% (39 od 150) djece koja su primala samo ondansetron.
English: Emend 165 mg capsules were shown to be bioequivalent to Ivemend 150 mg, which means that like Ivemend it can also be used to prevent nausea and vomiting caused by chemotherapy.
Croatian: Utvrđeno je da su kapsule lijeka Emend od 165 mg bioekvivalentne kapsulama lijeka Ivemend od 150 mg, što znači da se, baš kao i Ivemend, može upotrebljavati za sprečavanje mučnine i povraćanja uzrokovanih kemoterapijom.
English: Emend makes chemotherapy more tolerable for the patient.
Croatian: Emend bolesniku olakšava podnošenje kemoterapije.
English: What is Emend used for?
Croatian: Za što se Emend koristi?
English: Looking at the results of the two cisplatin studies taken together, 68% of the patients taking Emend had no nausea or vomiting over five days (352 out of 520), compared with 48% of the patients who did not take it (250 out of 523).
Croatian: Promatrajući rezultate dvaju istodobno provedenih ispitivanja cisplatina, u 68% bolesnika koji su primali Emend nisu zabilježeni mučnina i povraćanje u razdoblju od pet dana (352 od 520), u usporedbi s 48% bolesnika koji ga nisu primali (250 od 523).
English: In children, the most common side effects are hiccups and flushing.
Croatian: U djece su najčešće nuspojave štucanje i crvenilo uz osjećaj vrućine.
English: In the study of chemotherapy that is a moderate trigger of nausea and vomiting, 51% of the patients taking Emend had no nausea or vomiting (220 out of 433), compared with 43% of the patients who did not take it (180 out of 424).
Croatian: U ispitivanju kemoterapije koja izaziva umjerenu mučninu i povraćanje, u 51% bolesnika koji su primali Emend nisu zabilježeni mučnina i povraćanje (220 od 433), u usporedbi s 43% bolesnika koji ga nisu primali (180 od 424).
English: Looking at the results of both studies together, 55% of the patients (298 out of 541) taking Emend capsules at a dose of 40 mg had a complete response, compared with 49% of the patients who received ondansetron (258 out of 526).
Croatian: Promatrajući rezultate obaju ispitivanja zajedno, u 55% bolesnika (298 od 541) koji su uzimali kapsule lijeka Emend u dozi od 40 mg zabilježena je potpuna reakcija, u usporedbi s 49% bolesnika koji su primali ondansetron (258 od
English: The main measure of effectiveness was based on how many patients had a ‘complete response', which was defined as no vomiting, retching or dry heaves and no need for any other medication to control nausea and vomiting 25 to 120 hours after the start of chemotherapy (delayed phase).The study also looked at how many patients achieved a complete response in the first 24 hours after chemotherapy (acute phase).
Croatian: Glavna mjera učinkovitosti temeljena je na broju bolesnika kod kojih je zabilježena „potpuna reakcija”, koja se definira kao izostanak povraćanja, neuspješnog pokušaja povraćanja ili podražaja na povraćanje te izostanak potrebe za drugim lijekovima za kontrolu mučnine i povraćanja od 25 do 120 sati nakon početka kemoterapije (zakašnjela faza).
English: How is Emend used?
Croatian: Kako se Emend koristi?
English: How does Emend work?
Croatian: Kako djeluje Emend?
English: What benefit has Emend shown during the studies?
Croatian: Koje su koristi lijeka Emend utvrđene u ispitivanjima?
English: For the full list of restrictions with Emend, see the package leaflet.
Croatian: Potpuni popis ograničenja pri primjeni lijeka Emend potražite u uputi o lijeku.
English: For the full list of all side effects reported with Emend, see the package leaflet.
Croatian: Potpuni popis nuspojava zabilježenih pri primjeni lijeka Emend potražite u uputi o lijeku.
English: Emend 165 mg capsules were compared with the authorised intravenous medicine Ivemend 150 mg. Ivemend contains a substance called fosaprepitant which is converted in the body into aprepitant.
Croatian: Kapsule lijeka Emend od 165 mg uspoređene su s odobrenim intravenoznim lijekom Ivemend 150 mg.
English: Blister (OPA/alu/PVC) 84 capsules
Croatian: Blister (OPA/alu/PVC) 84 kapsule
English: EU/1/17/1232/001 Miglustat Gen.Orph
Croatian: EU/1/17/1232/001 Miglustat Gen.Orph 100 mg Kapsula, tvrda
English: Drink it straight away.
Croatian: Popijte odmah.
English: Tell your doctor if you are taking, have recently taken or might take any other medicines
Croatian: Obavijestite svog liječnika ako uzimate, nedavno ste uzeli ili biste mogli uzeti bilo koje druge lijekove.
English: It will dissolve directly in your mouth, so that it can be easily swallowed.
Croatian: Rastopit će se izravno u vašim ustima, pa ćete je moći lako progutati.
English: Generally, delayed type reactions such as contact dermatitis may occur, but rarely immediate reactions with bronchospasm may occur.
Croatian: Općenito se mogu javiti odgođene reakcije kao što je kontaktni dermatitis, ali se rijetko javljaju neposredne reakcije s bronhospazmom.
English: These preservatives are known to cause urticaria.
Croatian: Poznato je da ovi konzervansi uzrokuju urtikariju.
English: 16 Elevated plasma prolactin levels were reported in 47.4% of adolescent patients.
Croatian: 16 Povišene razine prolaktina u plazmi prijavljene su u 47,4% adolescentnih bolesnika.
English: ZYPREXA VELOTAB belongs to a group of medicines called antipsychotics and is used to treat the following conditions:
Croatian: ZYPREXA VELOTAB pripada skupini lijekova koji se zovu antipsihotici i koristi se za liječenje sljedećih stanja:
English: Your doctor will tell you how many ZYPREXA VELOTAB tablets to take and how long you should continue to take them.
Croatian: Liječnik će Vam reći koliko ZYPREXA VELOTAB tableta trebate uzeti i koliko ćete ih dugo uzimati.
English: In clinical studies, the average olanzapine exposure was approximately 27% higher in adolescents.
Croatian: U kliničkim ispitivanjima prosječna izloženost olanzapinu bila je približno 27% viša u adolescenata.
English: May be harmful for people with phenylketonuria.
Croatian: Može biti štetan u osoba s fenilketonurijom.
English: The mean increase in olanzapine Cmax following fluvoxamine was 54 % in female nonsmokers and 77 % in male smokers.
Croatian: Srednja vrijednost porasta Cmax olanzapina nakon primjene fluvoksamina iznosila je 54% u žena nepušača i 77% u muškaraca pušača.
English: Keep this medicine out of sight and reach of children.
Croatian: Lijek čuvajte izvan pogleda i dohvata djece.
English: You can also place the tablet in a full glass or cup of water, orange juice, apple juice, milk or coffee, and stir.
Croatian: Tabletu također možete staviti u punu čašu ili šalicu vode, soka od naranče, soka od jabuke, mlijeka ili kave te promiješati.
English: This may occur immediately or some time after you take ZYPREXA VELOTAB.
Croatian: To se može dogoditi odmah ili neko vrijeme nakon uzimanja lijeka ZYPREXA VELOTAB.
English: Since the orodispersible tablet is fragile, it should be taken immediately on opening the blister.
Croatian: Budući da je raspadljiva tableta za usta krhka, treba je uzeti odmah nakon otvaranja blistera.
English: Alternatively, it may be dispersed in a full glass of water or other suitable beverage (orange juice, apple juice, milk or coffee) immediately before administration.
Croatian: Alternativno se može rastopiti u čaši punoj vode ili nekom drugom prikladnom napitku (soku od naranče, soku od jabuke, mlijeku ili kavi) netom prije primjene.
English: However, olanzapine (5-20 mg) demonstrated a comparable safety profile in female (n=467) as in male patients (n=869).
Croatian: Međutim, olanzapin (5-20 mg) je u bolesnica (n=467) pokazao profil sigurnosti usporediv s onim u bolesnika (n=869).
English: Do not handle the tablets with wet hands as the tablets may break up.
Croatian: Ne uzimajte tablete mokrim rukama jer se mogu prelomiti.
English: The frequency terms listed are defined as follows: Very common (≥ 1/10), common (≥ 1/100 to < 1/10), uncommon (≥ 1/1,000 to < 1/100), rare (≥ 1/10,000 to < 1/1,000), very rare (< 1/10,000), not known (cannot be estimated from the data available).
Croatian: Učestalost je definirana kako slijedi: vrlo često (≥ 1/10), često (≥ 1/100 i < 1/10), manje često (≥ 1/1000 i < 1/100), rijetko (≥ 1/10 000 i < 1/1000), vrlo rijetko (< 1/10 000), nepoznato (ne može se procijeniti iz dostupnih podataka).
English: Hold the blister strip at the edges and separate one blister cell from the rest of the strip by gently tearing along the perforations around it.
Croatian: Primite blister za rubove i odvojite jedno polje blistera od ostatka trake, pažljivo trgajući duž perforacija koje ga okružuju.
English: Orodispersible tablet is the technical name for a tablet which dissolves directly in your mouth, so that it can be easily swallowed.
Croatian: Raspadljiva tableta za usta je tehnički naziv za tabletu koja se rastopi izravno u ustima pa se može lako progutati.
English: In 44 patients with schizophrenia > 65 years of age, dosing from 5 to 20 mg/day was not associated with any distinguishing profile of adverse events.
Croatian: 44 bolesnika sa shizofrenijom u dobi iznad 65 godina doziranje od 5 do 20 mg/dan nije bilo povezano ni sa kakvim posebnim profilom nuspojava.
English: ZYPREXA VELOTAB is available in packs containing 28, 35, 56, 70 or 98 tablets.
Croatian: ZYPREXA VELOTAB dostupan je u pakiranjima s 28, 35, 56, 70 ili 98 tableta.
English: With some drinks, the mixture may change colour and possibly become cloudy.
Croatian: Ako se lijek uzima s pićem, mješavina može promijeniti boju i postati mutna.
English: ZYPREXA VELOTAB with alcohol
Croatian: ZYPREXA VELOTAB s alkoholom
English: You should not be given this medicine when breast-feeding, as small amounts of ZYPREXA VELOTAB can pass into breast milk.
Croatian: Ne biste smjeli uzimati ovaj lijek dok dojite, jer se male količine lijeka ZYPREXA VELOTAB mogu izlučiti u majčino mlijeko.
English: In patients with Parkinson's disease ZYPREXA VELOTAB may worsen the symptoms.
Croatian: U bolesnika koji boluju od Parkinsonove bolesti, ZYPREXA VELOTAB može pogoršati simptome.
English: (including pulmonary embolism and deep vein thrombosis) (see section 4.4)
Croatian: (uključujući plućnu emboliju i duboku vensku trombozu) (vidjeti dio 4.4)
English: Carefully peel off the backing.
Croatian: Pažljivo odvojite stražnji dio.
English: You should take your ZYPREXA VELOTAB tablets once a day following the advice of your doctor.
Croatian: ZYPREXA VELOTAB tablete morate uzimati jednom dnevno pridržavajući se savjeta svog liječnika.
English: Yellow, round, freeze dried, rapid-dispersing preparation to be placed in the mouth or alternatively to be dispersed in water or other suitable beverage for administration.
Croatian: Žuti, okrugli, liofilizirani, brzo topljivi preparat koji se stavlja u usta ili se alternativno može rastopiti u vodi ili nekom drugom napitku prikladnom za primjenu.
English: • carbamazepine (an anti-epileptic and mood stabiliser), fluvoxamine (an antidepressant) or ciprofloxacin (an antibiotic) - it may be necessary to change your ZYPREXA VELOTAB dose.
Croatian: • karbamazepin (antiepileptik i stabilizator raspoloženja), fluvoksamin (antidepresiv) ili ciprofloksacin (antibiotik) - možda će biti potrebno promijeniti dozu lijeka ZYPREXA VELOTAB.
English: ZYPREXA VELOTAB should be stored in its original pack in order to protect from light and moisture.
Croatian: ZYPREXA VELOTAB treba čuvati u originalnom pakiranju radi zaštite od svjetlosti i vlage.
English: Do not drink any alcohol if you have been given ZYPREXA VELOTAB as together with alcohol it may make you feel drowsy.
Croatian: Nemojte piti alkohol ako uzimate ZYPREXA VELOTAB jer u kombinaciji s alkoholom može izazvati omamljenost.
English: Acute symptoms such as sweating, insomnia, tremor, anxiety, nausea, or vomiting have been reported rarely ( ≥ 0.01 % and < 0.1 %) when olanzapine is stopped abruptly.
Croatian: Akutni simptomi kao što su znojenje, nesanica, tremor, anksioznost, mučnina ili povraćanje rijetko su prijavljivani (≥ 0,01% i < 0,1%) nakon naglog prekida uzimanja olanzapina.
English: The following symptoms may occur in newborn babies, of mothers that have used ZYPREXA VELOTAB in the last trimester (last three months of their pregnancy): shaking, muscle stiffness and/or weakness, sleepiness, agitation, breathing problems, and difficulty in feeding.
Croatian: Sljedeći simptomi mogu se pojaviti u novorođenčadi majki koje su koristile ZYPREXA VELOTAB u posljednjem tromjesečju (zadnja tri mjeseca trudnoće): drhtanje, ukočenost mišića i/ili slabost, pospanost, uznemirenost, tegobe s disanjem te poteškoće u hranjenju.
English: Olanzapine administered with lithium or valproate resulted in increased levels (≥ 10%) of tremor, dry mouth, increased appetite, and weight gain.
Croatian: Olanzapin primijenjen s litijem ili valproatom rezultirao je povećanim razinama (≥ 10%) tremora, suhoće usta, povećanjem apetita i povećanjem tjelesne težine.
English: • The use of ZYPREXA VELOTAB in elderly patients with dementia is not recommended as it may have serious side effects.
Croatian: • Primjena lijeka ZYPREXA VELOTAB u starijih bolesnika s demencijom (zaboravljivošću) se ne preporučuje jer mogu nastati teške nuspojave.
English: However, the incidence of death was higher in olanzapine-treated than in placebotreated patients independent of these risk factors.
Croatian: Međutim, incidencija smrtnosti bila je veća u bolesnika liječenih olanzapinom nego u bolesnika koji su primali placebo, neovisno o ovim čimbenicima rizika.
English: It is important that you carry on taking ZYPREXA VELOTAB for as long as your doctor tells you.
Croatian: Važno je da nastavite uzimati ZYPREXA VELOTAB onoliko dugo koliko Vam je liječnik rekao.
English: Studies in patients aged 13-17 years showed various adverse reactions, including weight gain, changes in metabolic parameters and increases in prolactin levels(see sections 4.8 and 5.1).
Croatian: Ispitivanja u bolesnika u dobi od 13 do 17 godina pokazala su različite nuspojave, uključujući povećanje tjelesne težine, promjene metaboličkih parametara te porast razina prolaktina (vidjeti dijelove 4.8 i 5.1).
English: Hepatitis (including hepatocellular, cholestatic or mixed liver injury)11
Croatian: (uključujući hepatocelularno, kolestatsko ili mješovito oštećenje jetre)11
English: The magnitude of weight gain and the proportion of adolescent patients who had clinically significant weight gain were greater with long-term exposure (at least 24 weeks) than with short-term exposure.
Croatian: Povećanje tjelesne težine i udio adolescentnih bolesnika koji su imali klinički značajno povećanje tjelesne težine bili su veći tijekom dugotrajnog izlaganja (najmanje 24 tjedana)
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 3 February 2000
Croatian: Datum prvog odobrenja: 3. veljače 2000.
English: The daily dose of ZYPREXA VELOTAB is between 5 mg and 20 mg.
Croatian: Dnevna doza lijeka ZYPREXA VELOTAB iznosi između 5 mg i 20 mg.
English: Long-term olanzapine treatment (up to 12 months) for recurrence prevention in patients with bipolar disorder was associated with an increase of ≥ 7% from baseline body weight in 39.9% of patients.
Croatian: Dugotrajno liječenje olanzapinom (do 12 mjeseci) radi prevencije relapsa u bolesnika s bipolarnim poremećajem bilo je povezano s povećanjem tjelesne težine ≥ 7% od početne tjelesne težine u 39,9% bolesnika.
English: Other medicines and ZYPREXA VELOTAB
Croatian: Drugi lijekovi i ZYPREXA VELOTAB
English: ZYPREXA VELOTAB has been shown to prevent recurrence of these symptoms in patients with bipolar disorder whose manic episode has responded to olanzapine treatment.
Croatian: Pokazalo se da ZYPREXA VELOTAB sprječava ponavljanje tih simptoma u bolesnika s bipolarnim poremećajem u kojih je epizoda manije reagirala na liječenje olanzapinom.
English: Consult your doctor if your symptoms return but do not stop taking ZYPREXA VELOTAB unless your doctor tells you to.
Croatian: posavjetujte se sa svojim liječnikom, ali nemojte prestati uzimati ZYPREXA VELOTAB dok Vam liječnik to ne kaže.
English: Aluminium blister strips in cartons of 28, 35, 56, 70 or 98 orodispersible tablets per carton.
Croatian: Aluminijski blisteri u kutijama s 28, 35, 56, 70 ili 98 raspadljivih tableta za usta.
English: • If you are allergic (hypersensitive) to olanzapine or any of the other ingredients of this medicine (listed in section 6).
Croatian: Nemojte uzimati ZYPREXA VELOTAB • Ako ste alergični (preosjetljivi) na olanzapin ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.).
English: ZYPREXA VELOTAB orodispersible tablet should be placed in the mouth, where it will rapidly disperse in saliva, so it can be easily swallowed.
Croatian: ZYPREXA VELOTAB raspadljivu tabletu za usta treba staviti u usta, gdje se brzo rastapa u slini te se može lako progutati.
English: • Weight gain has been seen in patients taking ZYPREXA VELOTAB.
Croatian: • Zapaženo je povećanje tjelesne težine u bolesnika koji uzimaju ZYPREXA VELOTAB.
English: Olanzapine orodispersible tablet is bioequivalent to olanzapine coated tablets, with a similar rate and extent of absorption.
Croatian: Olanzapin raspadljiva tableta za usta je bioekvivalent obloženim tabletama olanzapina, sa sličnom brzinom i opsegom apsorpcije.